0001104659-25-029920.txt : 20250331 0001104659-25-029920.hdr.sgml : 20250331 20250331163129 ACCESSION NUMBER: 0001104659-25-029920 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250327 FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamill John P. CENTRAL INDEX KEY: 0001716213 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 25793830 MAIL ADDRESS: STREET 1: 4092 NEW HOPE ROAD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 215-948-4119 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 tm2510809-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2025-03-27 0 0001781983 Aprea Therapeutics, Inc. APRE 0001716213 Hamill John P. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 0 1 0 0 SrVP/CFO/Prin Fin & Acct Ofcr 0 Common Stock 2025-03-27 4 A 0 3365 0.00 A 22733 D Stock Options (Right to Buy) 2.20 2025-03-27 4 A 0 13460 0.00 A 2035-03-28 Common Stock 13460 13460 D These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 27, 2026, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions. Twenty-five percent of these options vest on March 27, 2026, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions. /s/ John Hamill 2025-03-31